Fact CheckerSign in

NCT06300216Not yet recruiting

A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors

Source: ClinicalTrials.gov · Last updated 8 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of this multicenter, open-label, observational study is to evaluate the safety and efficacy of octreotide microspheres in the treatment of advanced neuroendocrine tumors in real clinical practice, especially to evaluate the treatment of octreotide microspheres in various subgroups of neuroendocrine tumor patients.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
25 Feb 2024
Start date
26 Mar 2024
Primary completion date
26 Nov 2027
Lead sponsor
Qilu Hospital of Shandong University
NCT number
NCT06300216

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 26 Mar 2024 to the primary completion date, 26 Nov 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Confirmed pregnant or lactating women;
  • Participating in any research with intervention measures outside of routine clinical practice;
  • Other situations unsuitable for inclusion in the study determined by the researcher.

Who the study is looking for

  • Sign an informed consent form and voluntarily participate in this study;
  • Patients with unresectable or metastatic neuroendocrine tumors confirmed by histopathology. Patients with recurrence and progression after surgery or local treatment can also be included in the study;
  • Age ≥ 18 years old;
  • Treatment with octreotide microspheres.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Qilu Hospital of Shandong University
Coordinator of this site? Confirm its status
JinanChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.